Literature DB >> 25815462

Apoptosis of HL-60 human leukemia cells induced by Asiatic acid through modulation of B-cell lymphoma 2 family proteins and the mitogen-activated protein kinase signaling pathway.

Qiuling Wu1, Tingting Lv1, Yan Chen1, Lu Wen1, Junli Zhang1, Xudong Jiang1, Fang Liu1.   

Abstract

The toxicities of conventional chemotherapeutic agents to normal cells restrict their dosage and clinical efficacy in acute leukemia; therefore, it is important to develop novel chemotherapeutics, including natural products, which selectively target cancer-specific pathways. The present study aimed to explore the effect of the chemopreventive agent asiatic acid (AA) on the proliferation and apoptotic rate of the leukemia cell line HL-60 and investigated the mechanisms underlying its anti-tumor activity. The effect of AA on the proliferation of HL-60 cells was evaluated using the MTT assay. Annexin V-fluorescein isothiocyanate/propidium iodide double staining followed by flow cytometric analysis as well as Hoechst 33258 staining were used to analyze the apoptotic rate of the cells. Furthermore, changes of survivin, B-cell lymphoma 2 (Bcl-2), myeloid cell leukemia 1 (Mcl-1), extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK) and p38 expressions were detected by western blot analysis. AA blocked the growth of HL-60 cells in a dose- and time-dependent manner. The IC50-value of AA on HL-60 cells was 46.67 ± 5.08 µmol/l for 24 h. AA induced apoptosis in a dose-dependent manner, which was inhibited in the presence of Z-DEVD-FMK, a specific inhibitor of caspase. The anti-apoptotic proteins Bcl-2, Mcl-1 and survivin were downregulated by AA in a dose-dependent manner. Concurrently, AA inhibited ERK and p38 phosphorylation in a dose-dependent manner, while JNK phosphorylation was not affected. In conclusion, the present study indicated that the p38 and ERK pathways, as well as modulation of Bcl-2 family and survivin proteins were key regulators of apoptosis induced in HL-60 cells in response to AA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25815462     DOI: 10.3892/mmr.2015.3534

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  6 in total

Review 1.  Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise.

Authors:  Mohamed Fizur Nagoor Meeran; Sameer N Goyal; Kapil Suchal; Charu Sharma; Chandragouda R Patil; Shreesh K Ojha
Journal:  Front Pharmacol       Date:  2018-09-04       Impact factor: 5.810

Review 2.  Targeting MCL-1 in hematologic malignancies: Rationale and progress.

Authors:  Andrew H Wei; Andrew W Roberts; Andrew Spencer; Aaron Seth Rosenberg; David Siegel; Roland B Walter; Sean Caenepeel; Paul Hughes; Zach McIver; Khalid Mezzi; Phuong Khanh Morrow; Anthony Stein
Journal:  Blood Rev       Date:  2020-02-21       Impact factor: 8.250

3.  Inferring gene and protein interactions using PubMed citations and consensus Bayesian networks.

Authors:  Anthony Deeter; Mark Dalman; Joseph Haddad; Zhong-Hui Duan
Journal:  PLoS One       Date:  2017-10-19       Impact factor: 3.240

4.  Asiatic acid inhibits proliferation, migration and induces apoptosis by regulating Pdcd4 via the PI3K/Akt/mTOR/p70S6K signaling pathway in human colon carcinoma cells.

Authors:  Yajuan Hao; Jiawei Huang; Yun Ma; Wancheng Chen; Qin Fan; Xuegang Sun; Meng Shao; Hongbing Cai
Journal:  Oncol Lett       Date:  2018-04-04       Impact factor: 2.967

5.  Asiatic Acid, Extracted from Centella asiatica and Induces Apoptosis Pathway through the Phosphorylation p38 Mitogen-Activated Protein Kinase in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.

Authors:  Yen-Tze Liu; Yi-Ching Chuang; Yu-Sheng Lo; Chia-Chieh Lin; Yi-Ting Hsi; Ming-Ju Hsieh; Mu-Kuan Chen
Journal:  Biomolecules       Date:  2020-01-25

6.  Endothelial damage and a thin intercellular fibrin network promote haemorrhage in acute promyelocytic leukaemia.

Authors:  Chunxu Wang; Muxin Yu; Peng Zhou; Baorong Li; Yingmiao Liu; Lixiu Wang; Xiaojing Chen; Jingwen Du; Yufeng Wang; Jinming Zhang; Haijiao Jing; Yiming Feng; Yue Zhang; Yueyue Li; Zengxiang Dong; Shaohong Fang; Valerie A Novakovic; Jin Zhou; Jialan Shi
Journal:  EBioMedicine       Date:  2020-09-16       Impact factor: 8.143

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.